Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU™ [Immune Globulin ...

Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to ...

High discontinuation rates of semaglutide are observed in the US, Japan, and Denmark, driven by financial barriers and medication intolerance. Patients with chronic conditions, who would benefit most ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...

A Japanese organization is displaying paintings by young cancer patients at medical institutions and other facilities across ...

Add Yahoo as a preferred source to see more of our stories on Google. The author studied medicine in Japan.Courtesy of Vikram Madireddy Vikram Madireddy is a medical student who studied in the UK, ...

The proportion of male PBC patients in Japan nearly doubled from 12.4% to 20.6% between 2010 and 2021, while the mean age at diagnosis increased by approximately 5 years, suggesting PBC should no ...

Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...